Siemens Healthineers (ETR:SHL) PT Set at €75.00 by Deutsche Bank Aktiengesellschaft

Siemens Healthineers (ETR:SHL) has been given a €75.00 ($85.23) target price by research analysts at Deutsche Bank Aktiengesellschaft in a report issued on Thursday, Borsen Zeitung reports. Deutsche Bank Aktiengesellschaft’s price objective suggests a potential upside of 24.96% from the stock’s current price.

Several other equities analysts also recently issued reports on the stock. Barclays set a €60.00 ($68.18) price objective on shares of Siemens Healthineers in a report on Friday, December 17th. Nord/LB set a €60.00 ($68.18) price objective on shares of Siemens Healthineers in a research report on Tuesday, January 4th. Jefferies Financial Group set a €62.00 ($70.45) price objective on shares of Siemens Healthineers in a research report on Tuesday, November 23rd. Credit Suisse Group set a €71.00 ($80.68) price target on shares of Siemens Healthineers in a research report on Thursday, November 18th. Finally, Berenberg Bank set a €75.00 ($85.23) price objective on shares of Siemens Healthineers in a report on Tuesday, November 23rd. Five analysts have rated the stock with a hold rating and eight have given a buy rating to the company. Based on data from MarketBeat, Siemens Healthineers has a consensus rating of “Buy” and an average price target of €61.30 ($69.66).

Shares of SHL opened at €59.58 ($67.70) on Thursday. The stock has a market capitalization of $66.89 billion and a price-to-earnings ratio of 38.23. The company has a debt-to-equity ratio of 87.62, a quick ratio of 0.74 and a current ratio of 1.08. The stock has a fifty day moving average of €63.75 and a 200-day moving average of €59.05. Siemens Healthineers has a 52 week low of €41.98 ($47.70) and a 52 week high of €67.66 ($76.89).

About Siemens Healthineers

Siemens Healthineers AG, through its subsidiaries, develops, manufactures, and distributes imaging, diagnostic, and advanced therapies products and services to healthcare providers worldwide. The company operates through three segments; Imaging, Diagnostics, and Advanced Therapies. The Imaging segment offers magnetic resonance, computed tomography, X-ray, molecular imaging, and ultrasound systems.

Read More: What is quantitative easing?

Analyst Recommendations for Siemens Healthineers (ETR:SHL)

Receive News & Ratings for Siemens Healthineers Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Siemens Healthineers and related companies with MarketBeat.com's FREE daily email newsletter.